Incisive Genetics is a Vancouver biotechnology company developing delivery technology for gene editing therapies. The company’s core platform, the Incisive Delivery System, is built around lipid nanoparticle delivery intended to improve the safe and effective in vivo delivery of gene-editing machinery for CRISPR-based and other genetic medicine applications.